Global Decentralized Clinical Trial Software Supply, Demand and Key Producers, 2023-2029

December 2023 | 172 pages | ID: GA837480CFDCEN
GlobalInfoResearch

Abstracts

The global Decentralized Clinical Trial Software market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Decentralized Clinical Trial Software demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Decentralized Clinical Trial Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Decentralized Clinical Trial Software that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Decentralized Clinical Trial Software total market, 2018-2029, (USD Million)

Global Decentralized Clinical Trial Software total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Decentralized Clinical Trial Software total market, key domestic companies and share, (USD Million)

Global Decentralized Clinical Trial Software revenue by player and market share 2018-2023, (USD Million)

Global Decentralized Clinical Trial Software total market by Type, CAGR, 2018-2029, (USD Million)

Global Decentralized Clinical Trial Software total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Decentralized Clinical Trial Software market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medrio, Medable, TCS, Castor EDC, THREAD, ObvioHealth, Power, Veeva and SAHMRI, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Decentralized Clinical Trial Software market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Decentralized Clinical Trial Software Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Decentralized Clinical Trial Software Market, Segmentation by Type

• Web-based
• Cloud-based

Global Decentralized Clinical Trial Software Market, Segmentation by Application

• Medical Device & Diagnostics
• Biotech & Pharma
• Contract Research Organizations
• Academic Research
• Others

Companies Profiled:

• Medrio
• Medable
• TCS
• Castor EDC
• THREAD
• ObvioHealth
• Power
• Veeva
• SAHMRI
• IMI CARE
• DNDi
• Clario
• Castor
• Curebase
• Infiuss
• AGILE
• OpenClinica
• ClinCapture
• DFdiscover
• ClinPlus CTMS
• Dacima Clinical Suite
• Smartsheet
• Snappii
• RealTime-CTMS

Key Questions Answered

1. How big is the global Decentralized Clinical Trial Software market?

2. What is the demand of the global Decentralized Clinical Trial Software market?

3. What is the year over year growth of the global Decentralized Clinical Trial Software market?

4. What is the total value of the global Decentralized Clinical Trial Software market?

5. Who are the major players in the global Decentralized Clinical Trial Software market?

Contents

1 SUPPLY SUMMARY

1.1 Decentralized Clinical Trial Software Introduction
1.2 World Decentralized Clinical Trial Software Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Decentralized Clinical Trial Software Total Market by Region (by Headquarter Location)
  1.3.1 World Decentralized Clinical Trial Software Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Decentralized Clinical Trial Software Market Size (2018-2029)
  1.3.3 China Decentralized Clinical Trial Software Market Size (2018-2029)
  1.3.4 Europe Decentralized Clinical Trial Software Market Size (2018-2029)
  1.3.5 Japan Decentralized Clinical Trial Software Market Size (2018-2029)
  1.3.6 South Korea Decentralized Clinical Trial Software Market Size (2018-2029)
  1.3.7 ASEAN Decentralized Clinical Trial Software Market Size (2018-2029)
  1.3.8 India Decentralized Clinical Trial Software Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Decentralized Clinical Trial Software Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Decentralized Clinical Trial Software Major Market Trends

2 DEMAND SUMMARY

2.1 World Decentralized Clinical Trial Software Consumption Value (2018-2029)
2.2 World Decentralized Clinical Trial Software Consumption Value by Region
  2.2.1 World Decentralized Clinical Trial Software Consumption Value by Region (2018-2023)
  2.2.2 World Decentralized Clinical Trial Software Consumption Value Forecast by Region (2024-2029)
2.3 United States Decentralized Clinical Trial Software Consumption Value (2018-2029)
2.4 China Decentralized Clinical Trial Software Consumption Value (2018-2029)
2.5 Europe Decentralized Clinical Trial Software Consumption Value (2018-2029)
2.6 Japan Decentralized Clinical Trial Software Consumption Value (2018-2029)
2.7 South Korea Decentralized Clinical Trial Software Consumption Value (2018-2029)
2.8 ASEAN Decentralized Clinical Trial Software Consumption Value (2018-2029)
2.9 India Decentralized Clinical Trial Software Consumption Value (2018-2029)

3 WORLD DECENTRALIZED CLINICAL TRIAL SOFTWARE COMPANIES COMPETITIVE ANALYSIS

3.1 World Decentralized Clinical Trial Software Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Decentralized Clinical Trial Software Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Decentralized Clinical Trial Software in 2022
  3.2.3 Global Concentration Ratios (CR8) for Decentralized Clinical Trial Software in 2022
3.3 Decentralized Clinical Trial Software Company Evaluation Quadrant
3.4 Decentralized Clinical Trial Software Market: Overall Company Footprint Analysis
  3.4.1 Decentralized Clinical Trial Software Market: Region Footprint
  3.4.2 Decentralized Clinical Trial Software Market: Company Product Type Footprint
  3.4.3 Decentralized Clinical Trial Software Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Decentralized Clinical Trial Software Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Decentralized Clinical Trial Software Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Decentralized Clinical Trial Software Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Decentralized Clinical Trial Software Consumption Value Comparison
  4.2.1 United States VS China: Decentralized Clinical Trial Software Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Decentralized Clinical Trial Software Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Decentralized Clinical Trial Software Companies and Market Share, 2018-2023
  4.3.1 United States Based Decentralized Clinical Trial Software Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Decentralized Clinical Trial Software Revenue, (2018-2023)
4.4 China Based Companies Decentralized Clinical Trial Software Revenue and Market Share, 2018-2023
  4.4.1 China Based Decentralized Clinical Trial Software Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Decentralized Clinical Trial Software Revenue, (2018-2023)
4.5 Rest of World Based Decentralized Clinical Trial Software Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Decentralized Clinical Trial Software Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Decentralized Clinical Trial Software Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Decentralized Clinical Trial Software Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Web-based
  5.2.2 Cloud-based
5.3 Market Segment by Type
  5.3.1 World Decentralized Clinical Trial Software Market Size by Type (2018-2023)
  5.3.2 World Decentralized Clinical Trial Software Market Size by Type (2024-2029)
  5.3.3 World Decentralized Clinical Trial Software Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Decentralized Clinical Trial Software Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Medical Device & Diagnostics
  6.2.2 Biotech & Pharma
  6.2.3 Contract Research Organizations
  6.2.4 Academic Research
  6.2.5 Academic Research
6.3 Market Segment by Application
  6.3.1 World Decentralized Clinical Trial Software Market Size by Application (2018-2023)
  6.3.2 World Decentralized Clinical Trial Software Market Size by Application (2024-2029)
  6.3.3 World Decentralized Clinical Trial Software Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Medrio
  7.1.1 Medrio Details
  7.1.2 Medrio Major Business
  7.1.3 Medrio Decentralized Clinical Trial Software Product and Services
  7.1.4 Medrio Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Medrio Recent Developments/Updates
  7.1.6 Medrio Competitive Strengths & Weaknesses
7.2 Medable
  7.2.1 Medable Details
  7.2.2 Medable Major Business
  7.2.3 Medable Decentralized Clinical Trial Software Product and Services
  7.2.4 Medable Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Medable Recent Developments/Updates
  7.2.6 Medable Competitive Strengths & Weaknesses
7.3 TCS
  7.3.1 TCS Details
  7.3.2 TCS Major Business
  7.3.3 TCS Decentralized Clinical Trial Software Product and Services
  7.3.4 TCS Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 TCS Recent Developments/Updates
  7.3.6 TCS Competitive Strengths & Weaknesses
7.4 Castor EDC
  7.4.1 Castor EDC Details
  7.4.2 Castor EDC Major Business
  7.4.3 Castor EDC Decentralized Clinical Trial Software Product and Services
  7.4.4 Castor EDC Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Castor EDC Recent Developments/Updates
  7.4.6 Castor EDC Competitive Strengths & Weaknesses
7.5 THREAD
  7.5.1 THREAD Details
  7.5.2 THREAD Major Business
  7.5.3 THREAD Decentralized Clinical Trial Software Product and Services
  7.5.4 THREAD Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 THREAD Recent Developments/Updates
  7.5.6 THREAD Competitive Strengths & Weaknesses
7.6 ObvioHealth
  7.6.1 ObvioHealth Details
  7.6.2 ObvioHealth Major Business
  7.6.3 ObvioHealth Decentralized Clinical Trial Software Product and Services
  7.6.4 ObvioHealth Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 ObvioHealth Recent Developments/Updates
  7.6.6 ObvioHealth Competitive Strengths & Weaknesses
7.7 Power
  7.7.1 Power Details
  7.7.2 Power Major Business
  7.7.3 Power Decentralized Clinical Trial Software Product and Services
  7.7.4 Power Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Power Recent Developments/Updates
  7.7.6 Power Competitive Strengths & Weaknesses
7.8 Veeva
  7.8.1 Veeva Details
  7.8.2 Veeva Major Business
  7.8.3 Veeva Decentralized Clinical Trial Software Product and Services
  7.8.4 Veeva Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Veeva Recent Developments/Updates
  7.8.6 Veeva Competitive Strengths & Weaknesses
7.9 SAHMRI
  7.9.1 SAHMRI Details
  7.9.2 SAHMRI Major Business
  7.9.3 SAHMRI Decentralized Clinical Trial Software Product and Services
  7.9.4 SAHMRI Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 SAHMRI Recent Developments/Updates
  7.9.6 SAHMRI Competitive Strengths & Weaknesses
7.10 IMI CARE
  7.10.1 IMI CARE Details
  7.10.2 IMI CARE Major Business
  7.10.3 IMI CARE Decentralized Clinical Trial Software Product and Services
  7.10.4 IMI CARE Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 IMI CARE Recent Developments/Updates
  7.10.6 IMI CARE Competitive Strengths & Weaknesses
7.11 DNDi
  7.11.1 DNDi Details
  7.11.2 DNDi Major Business
  7.11.3 DNDi Decentralized Clinical Trial Software Product and Services
  7.11.4 DNDi Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 DNDi Recent Developments/Updates
  7.11.6 DNDi Competitive Strengths & Weaknesses
7.12 Clario
  7.12.1 Clario Details
  7.12.2 Clario Major Business
  7.12.3 Clario Decentralized Clinical Trial Software Product and Services
  7.12.4 Clario Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 Clario Recent Developments/Updates
  7.12.6 Clario Competitive Strengths & Weaknesses
7.13 Castor
  7.13.1 Castor Details
  7.13.2 Castor Major Business
  7.13.3 Castor Decentralized Clinical Trial Software Product and Services
  7.13.4 Castor Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.13.5 Castor Recent Developments/Updates
  7.13.6 Castor Competitive Strengths & Weaknesses
7.14 Curebase
  7.14.1 Curebase Details
  7.14.2 Curebase Major Business
  7.14.3 Curebase Decentralized Clinical Trial Software Product and Services
  7.14.4 Curebase Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.14.5 Curebase Recent Developments/Updates
  7.14.6 Curebase Competitive Strengths & Weaknesses
7.15 Infiuss
  7.15.1 Infiuss Details
  7.15.2 Infiuss Major Business
  7.15.3 Infiuss Decentralized Clinical Trial Software Product and Services
  7.15.4 Infiuss Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.15.5 Infiuss Recent Developments/Updates
  7.15.6 Infiuss Competitive Strengths & Weaknesses
7.16 AGILE
  7.16.1 AGILE Details
  7.16.2 AGILE Major Business
  7.16.3 AGILE Decentralized Clinical Trial Software Product and Services
  7.16.4 AGILE Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.16.5 AGILE Recent Developments/Updates
  7.16.6 AGILE Competitive Strengths & Weaknesses
7.17 OpenClinica
  7.17.1 OpenClinica Details
  7.17.2 OpenClinica Major Business
  7.17.3 OpenClinica Decentralized Clinical Trial Software Product and Services
  7.17.4 OpenClinica Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.17.5 OpenClinica Recent Developments/Updates
  7.17.6 OpenClinica Competitive Strengths & Weaknesses
7.18 ClinCapture
  7.18.1 ClinCapture Details
  7.18.2 ClinCapture Major Business
  7.18.3 ClinCapture Decentralized Clinical Trial Software Product and Services
  7.18.4 ClinCapture Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.18.5 ClinCapture Recent Developments/Updates
  7.18.6 ClinCapture Competitive Strengths & Weaknesses
7.19 DFdiscover
  7.19.1 DFdiscover Details
  7.19.2 DFdiscover Major Business
  7.19.3 DFdiscover Decentralized Clinical Trial Software Product and Services
  7.19.4 DFdiscover Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.19.5 DFdiscover Recent Developments/Updates
  7.19.6 DFdiscover Competitive Strengths & Weaknesses
7.20 ClinPlus CTMS
  7.20.1 ClinPlus CTMS Details
  7.20.2 ClinPlus CTMS Major Business
  7.20.3 ClinPlus CTMS Decentralized Clinical Trial Software Product and Services
  7.20.4 ClinPlus CTMS Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.20.5 ClinPlus CTMS Recent Developments/Updates
  7.20.6 ClinPlus CTMS Competitive Strengths & Weaknesses
7.21 Dacima Clinical Suite
  7.21.1 Dacima Clinical Suite Details
  7.21.2 Dacima Clinical Suite Major Business
  7.21.3 Dacima Clinical Suite Decentralized Clinical Trial Software Product and Services
  7.21.4 Dacima Clinical Suite Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.21.5 Dacima Clinical Suite Recent Developments/Updates
  7.21.6 Dacima Clinical Suite Competitive Strengths & Weaknesses
7.22 Smartsheet
  7.22.1 Smartsheet Details
  7.22.2 Smartsheet Major Business
  7.22.3 Smartsheet Decentralized Clinical Trial Software Product and Services
  7.22.4 Smartsheet Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.22.5 Smartsheet Recent Developments/Updates
  7.22.6 Smartsheet Competitive Strengths & Weaknesses
7.23 Snappii
  7.23.1 Snappii Details
  7.23.2 Snappii Major Business
  7.23.3 Snappii Decentralized Clinical Trial Software Product and Services
  7.23.4 Snappii Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.23.5 Snappii Recent Developments/Updates
  7.23.6 Snappii Competitive Strengths & Weaknesses
7.24 RealTime-CTMS
  7.24.1 RealTime-CTMS Details
  7.24.2 RealTime-CTMS Major Business
  7.24.3 RealTime-CTMS Decentralized Clinical Trial Software Product and Services
  7.24.4 RealTime-CTMS Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023)
  7.24.5 RealTime-CTMS Recent Developments/Updates
  7.24.6 RealTime-CTMS Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Decentralized Clinical Trial Software Industry Chain
8.2 Decentralized Clinical Trial Software Upstream Analysis
8.3 Decentralized Clinical Trial Software Midstream Analysis
8.4 Decentralized Clinical Trial Software Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION


10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Decentralized Clinical Trial Software Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Decentralized Clinical Trial Software Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Decentralized Clinical Trial Software Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Decentralized Clinical Trial Software Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Decentralized Clinical Trial Software Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Decentralized Clinical Trial Software Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Decentralized Clinical Trial Software Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Decentralized Clinical Trial Software Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Decentralized Clinical Trial Software Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Decentralized Clinical Trial Software Players in 2022
Table 12. World Decentralized Clinical Trial Software Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Decentralized Clinical Trial Software Company Evaluation Quadrant
Table 14. Head Office of Key Decentralized Clinical Trial Software Player
Table 15. Decentralized Clinical Trial Software Market: Company Product Type Footprint
Table 16. Decentralized Clinical Trial Software Market: Company Product Application Footprint
Table 17. Decentralized Clinical Trial Software Mergers & Acquisitions Activity
Table 18. United States VS China Decentralized Clinical Trial Software Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Decentralized Clinical Trial Software Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Decentralized Clinical Trial Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies Decentralized Clinical Trial Software Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Decentralized Clinical Trial Software Revenue Market Share (2018-2023)
Table 23. China Based Decentralized Clinical Trial Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies Decentralized Clinical Trial Software Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Decentralized Clinical Trial Software Revenue Market Share (2018-2023)
Table 26. Rest of World Based Decentralized Clinical Trial Software Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Decentralized Clinical Trial Software Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Decentralized Clinical Trial Software Revenue Market Share (2018-2023)
Table 29. World Decentralized Clinical Trial Software Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Decentralized Clinical Trial Software Market Size by Type (2018-2023) & (USD Million)
Table 31. World Decentralized Clinical Trial Software Market Size by Type (2024-2029) & (USD Million)
Table 32. World Decentralized Clinical Trial Software Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Decentralized Clinical Trial Software Market Size by Application (2018-2023) & (USD Million)
Table 34. World Decentralized Clinical Trial Software Market Size by Application (2024-2029) & (USD Million)
Table 35. Medrio Basic Information, Area Served and Competitors
Table 36. Medrio Major Business
Table 37. Medrio Decentralized Clinical Trial Software Product and Services
Table 38. Medrio Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Medrio Recent Developments/Updates
Table 40. Medrio Competitive Strengths & Weaknesses
Table 41. Medable Basic Information, Area Served and Competitors
Table 42. Medable Major Business
Table 43. Medable Decentralized Clinical Trial Software Product and Services
Table 44. Medable Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Medable Recent Developments/Updates
Table 46. Medable Competitive Strengths & Weaknesses
Table 47. TCS Basic Information, Area Served and Competitors
Table 48. TCS Major Business
Table 49. TCS Decentralized Clinical Trial Software Product and Services
Table 50. TCS Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. TCS Recent Developments/Updates
Table 52. TCS Competitive Strengths & Weaknesses
Table 53. Castor EDC Basic Information, Area Served and Competitors
Table 54. Castor EDC Major Business
Table 55. Castor EDC Decentralized Clinical Trial Software Product and Services
Table 56. Castor EDC Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Castor EDC Recent Developments/Updates
Table 58. Castor EDC Competitive Strengths & Weaknesses
Table 59. THREAD Basic Information, Area Served and Competitors
Table 60. THREAD Major Business
Table 61. THREAD Decentralized Clinical Trial Software Product and Services
Table 62. THREAD Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. THREAD Recent Developments/Updates
Table 64. THREAD Competitive Strengths & Weaknesses
Table 65. ObvioHealth Basic Information, Area Served and Competitors
Table 66. ObvioHealth Major Business
Table 67. ObvioHealth Decentralized Clinical Trial Software Product and Services
Table 68. ObvioHealth Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. ObvioHealth Recent Developments/Updates
Table 70. ObvioHealth Competitive Strengths & Weaknesses
Table 71. Power Basic Information, Area Served and Competitors
Table 72. Power Major Business
Table 73. Power Decentralized Clinical Trial Software Product and Services
Table 74. Power Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Power Recent Developments/Updates
Table 76. Power Competitive Strengths & Weaknesses
Table 77. Veeva Basic Information, Area Served and Competitors
Table 78. Veeva Major Business
Table 79. Veeva Decentralized Clinical Trial Software Product and Services
Table 80. Veeva Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Veeva Recent Developments/Updates
Table 82. Veeva Competitive Strengths & Weaknesses
Table 83. SAHMRI Basic Information, Area Served and Competitors
Table 84. SAHMRI Major Business
Table 85. SAHMRI Decentralized Clinical Trial Software Product and Services
Table 86. SAHMRI Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. SAHMRI Recent Developments/Updates
Table 88. SAHMRI Competitive Strengths & Weaknesses
Table 89. IMI CARE Basic Information, Area Served and Competitors
Table 90. IMI CARE Major Business
Table 91. IMI CARE Decentralized Clinical Trial Software Product and Services
Table 92. IMI CARE Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. IMI CARE Recent Developments/Updates
Table 94. IMI CARE Competitive Strengths & Weaknesses
Table 95. DNDi Basic Information, Area Served and Competitors
Table 96. DNDi Major Business
Table 97. DNDi Decentralized Clinical Trial Software Product and Services
Table 98. DNDi Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. DNDi Recent Developments/Updates
Table 100. DNDi Competitive Strengths & Weaknesses
Table 101. Clario Basic Information, Area Served and Competitors
Table 102. Clario Major Business
Table 103. Clario Decentralized Clinical Trial Software Product and Services
Table 104. Clario Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Clario Recent Developments/Updates
Table 106. Clario Competitive Strengths & Weaknesses
Table 107. Castor Basic Information, Area Served and Competitors
Table 108. Castor Major Business
Table 109. Castor Decentralized Clinical Trial Software Product and Services
Table 110. Castor Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Castor Recent Developments/Updates
Table 112. Castor Competitive Strengths & Weaknesses
Table 113. Curebase Basic Information, Area Served and Competitors
Table 114. Curebase Major Business
Table 115. Curebase Decentralized Clinical Trial Software Product and Services
Table 116. Curebase Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Curebase Recent Developments/Updates
Table 118. Curebase Competitive Strengths & Weaknesses
Table 119. Infiuss Basic Information, Area Served and Competitors
Table 120. Infiuss Major Business
Table 121. Infiuss Decentralized Clinical Trial Software Product and Services
Table 122. Infiuss Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Infiuss Recent Developments/Updates
Table 124. Infiuss Competitive Strengths & Weaknesses
Table 125. AGILE Basic Information, Area Served and Competitors
Table 126. AGILE Major Business
Table 127. AGILE Decentralized Clinical Trial Software Product and Services
Table 128. AGILE Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. AGILE Recent Developments/Updates
Table 130. AGILE Competitive Strengths & Weaknesses
Table 131. OpenClinica Basic Information, Area Served and Competitors
Table 132. OpenClinica Major Business
Table 133. OpenClinica Decentralized Clinical Trial Software Product and Services
Table 134. OpenClinica Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. OpenClinica Recent Developments/Updates
Table 136. OpenClinica Competitive Strengths & Weaknesses
Table 137. ClinCapture Basic Information, Area Served and Competitors
Table 138. ClinCapture Major Business
Table 139. ClinCapture Decentralized Clinical Trial Software Product and Services
Table 140. ClinCapture Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. ClinCapture Recent Developments/Updates
Table 142. ClinCapture Competitive Strengths & Weaknesses
Table 143. DFdiscover Basic Information, Area Served and Competitors
Table 144. DFdiscover Major Business
Table 145. DFdiscover Decentralized Clinical Trial Software Product and Services
Table 146. DFdiscover Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. DFdiscover Recent Developments/Updates
Table 148. DFdiscover Competitive Strengths & Weaknesses
Table 149. ClinPlus CTMS Basic Information, Area Served and Competitors
Table 150. ClinPlus CTMS Major Business
Table 151. ClinPlus CTMS Decentralized Clinical Trial Software Product and Services
Table 152. ClinPlus CTMS Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. ClinPlus CTMS Recent Developments/Updates
Table 154. ClinPlus CTMS Competitive Strengths & Weaknesses
Table 155. Dacima Clinical Suite Basic Information, Area Served and Competitors
Table 156. Dacima Clinical Suite Major Business
Table 157. Dacima Clinical Suite Decentralized Clinical Trial Software Product and Services
Table 158. Dacima Clinical Suite Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 159. Dacima Clinical Suite Recent Developments/Updates
Table 160. Dacima Clinical Suite Competitive Strengths & Weaknesses
Table 161. Smartsheet Basic Information, Area Served and Competitors
Table 162. Smartsheet Major Business
Table 163. Smartsheet Decentralized Clinical Trial Software Product and Services
Table 164. Smartsheet Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 165. Smartsheet Recent Developments/Updates
Table 166. Smartsheet Competitive Strengths & Weaknesses
Table 167. Snappii Basic Information, Area Served and Competitors
Table 168. Snappii Major Business
Table 169. Snappii Decentralized Clinical Trial Software Product and Services
Table 170. Snappii Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 171. Snappii Recent Developments/Updates
Table 172. RealTime-CTMS Basic Information, Area Served and Competitors
Table 173. RealTime-CTMS Major Business
Table 174. RealTime-CTMS Decentralized Clinical Trial Software Product and Services
Table 175. RealTime-CTMS Decentralized Clinical Trial Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 176. Global Key Players of Decentralized Clinical Trial Software Upstream (Raw Materials)
Table 177. Decentralized Clinical Trial Software Typical Customers

LIST OF FIGURE

Figure 1. Decentralized Clinical Trial Software Picture
Figure 2. World Decentralized Clinical Trial Software Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Decentralized Clinical Trial Software Total Market Size (2018-2029) & (USD Million)
Figure 4. World Decentralized Clinical Trial Software Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Decentralized Clinical Trial Software Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Decentralized Clinical Trial Software Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Decentralized Clinical Trial Software Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Decentralized Clinical Trial Software Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Decentralized Clinical Trial Software Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Decentralized Clinical Trial Software Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Decentralized Clinical Trial Software Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Decentralized Clinical Trial Software Revenue (2018-2029) & (USD Million)
Figure 13. Decentralized Clinical Trial Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Decentralized Clinical Trial Software Consumption Value (2018-2029) & (USD Million)
Figure 16. World Decentralized Clinical Trial Software Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Decentralized Clinical Trial Software Consumption Value (2018-2029) & (USD Million)
Figure 18. China Decentralized Clinical Trial Software Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Decentralized Clinical Trial Software Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Decentralized Clinical Trial Software Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Decentralized Clinical Trial Software Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Decentralized Clinical Trial Software Consumption Value (2018-2029) & (USD Million)
Figure 23. India Decentralized Clinical Trial Software Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Decentralized Clinical Trial Software by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Decentralized Clinical Trial Software Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Decentralized Clinical Trial Software Markets in 2022
Figure 27. United States VS China: Decentralized Clinical Trial Software Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Decentralized Clinical Trial Software Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Decentralized Clinical Trial Software Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Decentralized Clinical Trial Software Market Size Market Share by Type in 2022
Figure 31. Web-based
Figure 32. Cloud-based
Figure 33. World Decentralized Clinical Trial Software Market Size Market Share by Type (2018-2029)
Figure 34. World Decentralized Clinical Trial Software Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Decentralized Clinical Trial Software Market Size Market Share by Application in 2022
Figure 36. Medical Device & Diagnostics
Figure 37. Biotech & Pharma
Figure 38. Contract Research Organizations
Figure 39. Academic Research
Figure 40. Others
Figure 41. Decentralized Clinical Trial Software Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source